Helix Company

Helix is the leading population genomics company working at the intersection of clinical care, research, and genomics. Its end-to-end platform enables health systems, life sciences companies, and payers to advance genomic research and accelerate the integration of genomic data into clinical care. Powered by one of the world's largest CLIA / CAP next-generation sequencing labs and its proprietary Exome+ assay, Helix supports all aspects of population genomics including recruitment and engagement, clinically actionable disease screening, return of results, and basic and translational research.
Technology: AI, Clinical Trials
Industry: Big Data, Bioinformatics, Biotechnology, Clinical Data Management, Genetics, Health Care, Personal Health
Headquarters: San Francisco Bay Area, Silicon Valley, West Coast
Founded Date: 15.07.2015
Employees Number: 101-250
Funding Status: Early Stage Venture
Acquisitions Number: 1
Investors Number: 9
Total Funding: $353M
Estimated Revenue: $10M to $50M
Last Funding Type: Grant

Visit Website
support@helix.company
https://twitter.com/my_helix
Register and Claim Ownership